D2 dopamine receptors enable Δ9-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration

British Journal of Pharmacology

Volumn 130, Issue 6, 2000, Pages 1201-1210

  Nava, F ^a   Carta, G ^b   Battasi, A M ^a   Gessa, G L ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Neuroscience SCARL   (Italy)

Author keywords

Acetylcholine; Working memory

Indexed keywords

ACETYLCHOLINE; CANNABINOID RECEPTOR ANTAGONIST; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; QUINPIROLE; RIMONABANT; SULPIRIDE; TETRAHYDROCANNABINOL;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; WORKING MEMORY;

EID: 0033928980     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703413     Document Type: Article

References (52)

1. 1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology, 116, 143-151.
2. ARNSTEN, A.F.T. & GOLDMAN-RAKIC, P.S. (1998). Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. Arch. Gen. Psychiatry, 55, 362-368.
3. BRODKIN, J. & MOERSCHBAECHER, J.M. (1997). SR 141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats. J. Pharmacol. Exp. Ther., 282, 1526-1532.
4. 1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J. Pharmacol. Exp. Ther., 283, 183-189.
5. 9-tetrahydrocannabinol-induced antinociception in rat. Eur. J. Pharmacol., 384, 153-156.
6. 9-tetrahydrocannabinol in rats. Brain Res., 809, 1-4.
7. CASTANEDA, E., MOSS, D.E., ODDIE, S.D. & WHISHAW, I.Q. (1991). THC does not affect striatal dopamine release: microdialysis in freely moving rats. Pharmacol. Biochem. Behav., 40, 587-591.
8. CHEN, J., MARMUR, R., PULLES, A., PAREDES, W. & GARDNER, E.L. (1993). Ventral tegmental microinjection of delta-9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: Evidence for local neural action by marijuana's psychoactive ingredient. Brain Res., 621, 65-70.
9. CHEN, J., PAREDES, W., LOWINSON, J.H. & GARDNER, E.L. (1990a). Delta9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur. J. Pharmacol., 190, 259-262.
10. 9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology, 102, 156-162.
11. 9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study. Neurosci. Lett., 129, 136-140.
12. CHILDERS, S.R. & DEADWYLER, S.A. (1996). Role of cyclic AMP in the actions of cannabinoid receptors. Biochem. Pharmacol., 52, 819-827.
13. COLLINS, D.R., PERTWEE, R.G. & DAVIES, S.N. (1995). Prevention by the cannabinoid antagonist SR141716A, of cannabinoid-mediate blockade of long-term potentiation in the rat hippocampal slice. Br. J. Pharmacol., 115, 869-870.
14. DAMSMA, G. & WESTERINK, B.H.C. (1991). A microdialysis and automated on-line analysis approach to study central cholinergic transmission in vivo. In Microdialysis in Neuroscience, ed. Robinson T.E., Justice J., pp. 237-252, Elsevier, Amsterdam.
15. DESIMONE, R. (1995). Is dopamine a missing link? Nature, 376, 549-550.
16. 1 receptors by cannabinoids. Eur. J. Neurosci., 10, 2825-2830.
17. DURSTEWITZ, D., KELC, M. & GUNTURKUN, O. (1999). A neurocomputational theory of the dopaminergic modulation of working memory functions. J. Neurosci., 19, 2807-2822.
18. GESSA, G.L., CASU, M.A., CARTA, G. & MASCIA, M.S. (1998a). Cannabinoids decrease acetycholine release in the medial prefrontal cortex and hippocampus, reversal by SR 141716A. Eur. J. Pharmacol., 355, 119-124.
19. GESSA, G.L., MASCIA, M.S., CASU, M.A. & CARTA, G. (1997). Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR141716A. Eur. J. Pharmacol., 327, R1-R2.
20. 1 receptors. Eur. J. Pharmacol., 341, 39-44.
21. GIFFORD, A.N. & ASHBY Jr, C.R. (1996). Electrically evoked acetylcholine release from hippocampal slice is inhibited by the cannabinoid receptor agonist, WIN55,212-2 and is potentiated by the cannabinoid antagonist, SR 141716A. J. Pharmacol. Exp. Ther., 277, 1431-1436.
22. GIFFORD, A.N., SAMIIAN, L., GATLEY, S.J. & ASHBY Jr, C.R. (1997). Examination of the effect of cannabinoid receptor agonist, CP55,940 on electrically evoked transmitter release from rat brain slices. Eur. J. Pharmacol., 324, 187-192.
23. 1 receptor. J. Neurosci., 17, 5327-5333.
24. HALL, W. & SOLOWIJ, N. (1998). Adverse effects of cannabis Lancet., 352, 1611-1616.
25. IMPERATO, A., ANGELUCCI, L., CASOLINI, P., ZOCCHI, A. & PUGLISI-ALLEGRA, S. (1992). Repeated stressful experiences differently affect limbic dopamine release during and following stress. Brain Res., 577, 194-199.
26. JENTSCH, J.D., ANDRUSIAK, E., TRAN, A., BOWERS Jr, M.B. & ROTH, R.H. (1997). Delta9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology, 16, 426-432.
27. LEVY, R. & GOLDMAN-RAKIC, P.S. (1999). Association of storage and processing functions in the dorsolateral prefrontal cortex of the non human primate. J. Neurosci., 19, 5149-5158.
28. LICHTMAN, A.H., DIMEN, K.R. & MARTIN, B.R. (1995). Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology, 119, 282-290.
29. 9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology, 126, 125-131.
30. 1 receptor antagonist SR 141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology, 140, 11-19.
31. MALLET, P.E. & BENINGER, R.J. (1996). The endogenous cannabinoid receptor agonist anandamide impairs memory in rats. Behav. Pharmacol., 7, 276-284.
32. MATSUDA, L.A., BONNER, T.I. & LOLAIT, S.J. (1993). Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol., 327, 535-550.
33. 1 dopamine receptor linked to adenyl cyclase activation. Proc. Natl. Acad. Sci. U.S.A., 87, 6723-6727.
34. MORROW, B.A., LEE, E.J.K., TAYLOR, J.R., ELSWORTH, J.D., NYE, H.E. & ROTH, R.H. (1997). (S)-(-)-HA 966, a gamma-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioural correlates of restraint stress, conditioned fear and cocaine sensitization. J. Pharmacol. Exp. Ther., 283, 712-721.
35. MURPHY, B.L., ARNSTEN, A.F., GOLDMAN-RAKIC, P.S. & ROTH, R.H. (1996). Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. U.S.A., 93, 1325-1329.
36. 9-tetrahydrocannabinol in rats. Pharmacol. Biochem. Behav., in press.
37. NORWICKY, A.V., TEYIER, T.J. & VARDARIS, R.M. (1987). The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res. Bull., 19, 663.
38. PAXINOS, G. & WATSON, C. (1986). The rat brain in stereotaxic coordinate. Academic Press, London.
39. 2 receptors. Pharmacol. Ther., 74, 129-180.
40. POPE Jr, H.G., GRIBER, A.J. & JURGELUN-TODD, D. (1995). The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend., 38, 25-34.
41. 1 dopamine receptors in prefrontal cortex involvement in working memory. Science, 251, 947-950.
42. 1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 583-589.
43. 1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rats. J. Neurosci., 18, 1613-1621.
44. SHEN, M,. PISER, T.M., SEYBOLD, V.S. & THAYER, S.A. (1996). Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 72, 169-177.
45. SIBLEY, D.R. & MONSMA, F.J. (1992). Molecular biology of dopamine receptors. Trends Pharmacol. Sci., 13, 61-69.
46. STELLA, N., SCHWEITZER, P. & PIOMELLI, D. (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature, 388, 773-778.
47. 1 opiod receptor mechanism. Science, 276, 2048-2050.
48. 1 cannabinoid receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 576-579.
49. THOMAS, H. (1993). Psychiatric symptoms in cannabis users. Br. J. Psychiatry, 163, 141-149.
50. WATANABE, M., KODAMA, T. & HIKOSAKA, K. (1997). Increase of extracellular dopamine in primate prefrontal cortex during a working memory task. J. Neurophysiol., 78, 2795-2798.
51. 1 receptors in prefrontal cortex. Nature, 376, 572-575.
52. 1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J. Neurosci., 17, 8528-8535.